Test Posting of e-newsletter

Stu's Views and MS News e-Newsletter 'MS Views and News' is unique in what we do. Bridging the gap to all major MS Organizations. Providing information and resources from our website, daily via our blog and weekly by our e-newsletter . -------------------------------------------------------------- In this week's edition: Stem Cell, CCSVI, Oral therapies, Handling the heat, Readying for your Appt with Neurologist. -------------------------------------------------------------- Tell us what you think of the design of this new e-newsletter, Write to: info@msviewsandnews.org -------------------------------------------------------------- "Providing You with 'MS Views and News', is What We Do" _______________________________ CLICK BELOW TO DONATE MSV&N is a 501©(3) organization as recognized by the Internal Revenue Service. Your gift is tax deductible to the extent permitted by law. This Week's Postings... Click each to review Struggling with Tight, Stiff Muscles? British lass saddles up How to Prepare for an Appointment with Your MS Neu... MS Society Headline News MS depression may be rooted in biology Compugen Discovered Protein Shown To Abolish Recur... Genmab Announces Interim Results of Ofatumumab Pha... Medical device to reduce the pain of needle inject... MS patient gets her wish for Liberation Frozen blood from stored samples can be used to ma... Yoga, tai chi, qigong and other exercises appear t... An MS Patient's response, to recent chatter of CCS... Research News on Oral MS Therapies The Multiple Sclerosis Society of Qatar (MSSQ) has... Brain atrophy responsible for depression in people... Progressive forms of Multiple Sclerosis may have n... Social Security is still a prime target for cuts Polar MS resources and Cooling Products Recent News Study of “Liberation Treatment” to Launch in Buffalo The University of Buffalo has announced that researchers there, led by the department of neurosurgery, have embarked on a landmark prospective randomized double-blinded study to test the safety and efficacy of interventional endovascular therapy—dubbed “liberation treatment”—on MS symptoms and progression. Ever since Paolo Zamboni, M.D., of the University of Ferrara, Italy, proposed more than a year ago that a blockage of major venous outflow from the brain and spinal cord in people with MS (a condition known as CCSVI) may be associated with the disease, the MS community has been anxious for further studies to distinguish the role of CCSVI in MS. PREMiSe (Prospective Randomized Endovascular therapy in Multiple Sclerosis) is a study to determine if endovascular intervention via balloon angioplasty to correct the blockages improves MS symptoms or progression To continue reading, click here Headline News Study of “Liberation Treatment” to Launch in Buffalo 6/30/2010 Energizer's "Kids Take Charge" Video Campaign Raises Funds for MSF 6/18/2010 Other MSVN sites ~...~... * View our e-newsletter archives by clicking here. * VISIT with our Sponsor links by clicking on their banners found on our website: http://www.msviewsandnews.org * Please visit the MS Views and News Bidding for Good Auction site. Click here to see what is available. OUR MISSION: 'MS Views and News' (MSVN) is dedicated to the global collection and distribution of current information concerning Multiple Sclerosis. In collaboration with other organizations, 'MS Views and News' uses state-of-the-art communication channels to provide information for those affected by, or interested in MS. _______________________________________________________________________ e-Newsletter Disclaimer: ***Editor's Note: The intent of this newsletter is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.